Status:
WITHDRAWN
Duration of Analgesia With Dexmedetomidine and Ropivacaine in Brachial Plexus Block
Lead Sponsor:
University of Florida
Conditions:
Analgesia
Pain, Acute
Eligibility:
All Genders
18-99 years
Phase:
PHASE4
Brief Summary
This is a prospective, randomized, double blind study of adding dexmedetomidine to ropivacaine for Brachial plexus block and assessing the analgesia with VAS pain scales(0-10), Satisfaction scale by V...
Detailed Description
In our institute ropivacaine is used for all the peripheral nerve blocks. This a prospective, randomized, double blind clinical trial study comparing the addition of dexmedetomidine vs ropivacaine alo...
Eligibility Criteria
Inclusion
- Age-18years and above
- Both male and female patients
- BMI-\>18
- Elective Subacute upper extremity fractures
Exclusion
- Chronic pain patients (Pain persisting for more than 3-6months or past the normal healing time of any injury, influences every aspect of a person's quality of life.)
- Patients with drug abuse history in the past 6 months
- ESRD
- Hepatic failure
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03385967
Start Date
April 1 2019
End Date
December 1 2019
Last Update
May 23 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.